Alnylam Pharmaceuticals
ALNY
#510
Rank
NZ$81.35 B
Marketcap
NZ$615.78
Share price
-0.17%
Change (1 day)
29.84%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company